| Literature DB >> 32280705 |
Qiang Cai1, Mei-Ling Gao2, Guan-Yu Chen1, Ling-Hui Pan1.
Abstract
BACKGROUND: How to effectively control the postoperative pain of patients is extremely important to clinicians. Transversus abdominis plane (TAP) block is a novel analgesic method reported to greatly decrease postoperative pain. However, in many areas, there still exists a phenomenon of surgeons using wound infiltration (WI) with conventional local anesthetics (not liposome anesthetics) as the main means to decrease postoperative pain because of traditional wisdom or convenience. Here, we compared the analgesic effectiveness of the two different methods to determine which method is more suitable for adult patients. Materials and methods. A systematic review and meta-analysis of randomized controlled trials (RCTs) comparing TAP block and WI without liposome anesthetics in adult patients were performed. Frequently used databases were extensively searched. The main outcomes were postoperative pain scores in different situations (at rest or during movement) and the time until the first use of rescue analgesics. The secondary outcomes were postoperative nausea and vomiting (PONV) incidence and patient satisfaction scores.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32280705 PMCID: PMC7125448 DOI: 10.1155/2020/8914953
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Flowchart of the literature search for the included studies.
Characteristics of the included studies.
| Author (publication year) | Age of patients (years) | Surgery | Anesthesia | Number of patients | Technology of TAP block/WI | Drug | Operative site |
|---|---|---|---|---|---|---|---|
| Atim, A. [ | Adults (30-63) | Hysterectomy | GA | TAP (18), WI (19) | US-guided bilateral injection/incision site infiltration | Bupivacaine | Lower abdomen |
| Ortiz, J. [ | Adults (18-64) | Laparoscopic cholecystectomy | GA | TAP (39), WI (35) | US-guided bilateral injection/trocar insertion site infiltration | Bupivacaine | Upper abdomen |
| Tolchard, S. [ | Adults (>16) | Laparoscopic cholecystectomy | GA | TAP (21), WI (22) | US-guided bilateral injection//trocar insertion site infiltration | Bupivacaine | Upper abdomen |
| Skjelsager, A. [ | Adults (18-80) | Open radical prostatectomy | GA | TAP (23), WI (25) | US-guided bilateral injection/incision site infiltration | Bupivacaine | Lower abdomen |
| Aydogmus, M. T. [ | Pregnant women (23-35) | Cesarean delivery | GA | TAP (35), WI (35) | US-guided bilateral injection/incision site infiltration | Levobupivacaine | Lower abdomen |
| Ibrahim, M. [ | Adults (>18) | Laparoscopic sleeve gastrectomy | GA | TAP (21), WI (21) | US-guided bilateral injection/trocar insertion site infiltration | Bupivacaine | Upper abdomen |
| Elamin, G. [ | Adults (18-85) | Elective laparoscopic cholecystectomy | GA | TAP (40), WI (40) | Laparoscope-guided bilateral injection/trocar insertion site infiltration | Bupivacaine | Upper abdomen |
| Gorkem, U. [ | Pregnant women (18-45) | Cesarean delivery | GA | TAP (42), WI (46) | US-guided bilateral injection/incision site infiltration | Bupivacaine | Lower abdomen |
| Rashid, A. [ | Adults (>18) | Elective laparoscopic colonic surgery | GA | TAP (28), WI (28) | US-guided bilateral injection/trocar insertion site infiltration | Bupivacaine | Lower abdomen |
| Tawfik, M. M. [ | Pregnant women (22-31) | Cesarean delivery | SA | TAP (39), WI (39) | US-guided bilateral injection/incision site infiltration | Bupivacaine | Lower abdomen |
| El sharkwy, I. A. [ | Women (>18) | Gynecologic laparoscopy | GA | TAP (42), WI (40) | US-guided bilateral injection/trocar insertion site infiltration | Bupivacaine | Lower abdomen |
| Kargar, R. [ | Adults (18-50) | Laparoscopic excision of endometriosis | GA | TAP (24), WI (21) | US-guided bilateral injection/trocar insertion site infiltration | Bupivacaine | Lower abdomen |
| Li, Q. [ | Adults (18-75) | Peritoneal dialysis catheter implantation | SA | TAP (20), WI (20) | US-guided unilateral injection/incision site infiltration | Ropivacaine | Lower abdomen |
| Mughal, A. [ | Adults (18-80) | Total extraperitoneal inguinal hernia repair | GA | TAP (30), WI (30) | Laparoscope-guided unilateral injection/incision site infiltration | Bupivacaine | Lower abdomen |
| Ruiz-Tovar [ | Adults (41-48) | Laparoscopic Roux-en-Ygastric bypass | GA | TAP (70), WI (70) | Laparoscope-guided bilateral injection/trocar insertion site infiltration | Bupivacaine | Upper abdomen |
GA: general anesthesia; SA: spinal epidural anesthesia; TAP: transversus abdominis plane; WI: wound infiltration; US: ultrasound.
Figure 2Risk of bias graph for the included studies.
Figure 3Risk of bias summary for the included studies. Green indicates low risk of bias; yellow indicates unclear risk of bias.
GRADE evidence profile for pain scores.
| Quality assessment | No. of patients | Effect | Quality | Importance | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| No. of studies | Design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | TAP | Wl | Absolute (95% CI) | ||
| Pain scores at rest at 1 h (measured with: VAS; better indicated by lower values) | |||||||||||
| 5 | Randomized trials | Serious1 | No serious inconsistency | No serious indirectness | Serious2 | Strong association3 | 143 | 141 | MD 0.32 lower (0.87 lower to 0.24 higher) | Moderate | Critical |
| Pain scores at rest at 2 h (measured with: VAS; better indicated by lower values) | |||||||||||
| 5 | Randomized trials | No serious | No serious inconsistency | No serious indirectness | Serious4 | Strong association3 | 121 | 121 | MD 0.76 lower (1.22 to 0.31 lower) | High | Critical |
| Pain scores at rest at 4 h (measured with: VAS; better indicated by lower values) | |||||||||||
| 3 | Randomized trials | No serious | No serious inconsistency | No serious indirectness | Serious2 | None | 80 | 79 | MD 0.57 lower (1.11 to 0.03 lower) | Moderate | Critical |
| Pain scores at rest at 6 h (measured with: VAS; better indicated by lower values) | |||||||||||
| 5 | Randomized trials | Serious5 | No serious inconsistency | No serious indirectness | Serious2 | Strong association3 | 146 | 151 | MD 0.87 lower (1.08 to 0.65 lower) | Moderate | Critical |
| Pain scores at rest at 12 h (measured with: VAS; better indicated by lower values) | |||||||||||
| 4 | Randomized trials | Serious1 | No serious inconsistency | No serious indirectness | Serious | Strong association3 | 144 | 142 | MD 0.78 lower (0.91 to 0.65 lower) | Moderate | Critical |
| Pain scores at rest at 24 h (measured with: VAS; better indicated by lower values) | |||||||||||
| 8 | Randomized trials | Serious6 | No serious inconsistency | No serious indirectness | Serious2 | Very strong association7 | 270 | 267 | MD 0.55 lower (0.73 to 0.37 lower) | High | Critical |
| Pain scores during movement at 1 h (measured with: VAS; better indicated by lower values) | |||||||||||
| 2 | Randomized trials | No serious | No serious inconsistency | No serious indirectness | No serious imprecision | None | 41 | 44 | MD 1.04 lower (2.07 lower to 0 higher) | High | Critical |
| Pain scores during movement at 2 h (measured with: VAS; better indicated by lower values) | |||||||||||
| 3 | Randomized trials | No serious | No serious inconsistency | No serious indirectness | No serious imprecision | None | 61 | 64 | MD 1.47 lower (2.32 to 0.62 lower) | High | Critical |
| Pain scores during movement at 4 h (measured with: VAS; better indicated by lower values) | |||||||||||
| 3 | Randomized trials | No serious | No serious inconsistency | No serious indirectness | Serious5 | None | 62 | 65 | MD 0.65 lower (1.24 to 0.06 lower) | Moderate | Critical |
| Pain scores during movement at 6 h (measured with: VAS; better indicated by lower values) | |||||||||||
| 3 | Randomized trials | No serious | No serious inconsistency | No serious indirectness | Serious6 | None | 62 | 65 | MD 0.73 lower (1.23 to 0.24 lower) | Moderate | Critical |
| Pain scores during movement at 24 h (measured with: VAS; better indicated by lower values) | |||||||||||
| 5 | Randomized trials | Serious6 | No serious inconsistency | No serious indirectness | Serious2 | Strong association3 | 119 | 122 | MD 0.85 lower (1.16 to 0.53 lower) | Moderate | Critical |
1One study did not mention the randomization method, and two studies did not mention how the blindness method was implemented.
2Some data were collected from charts by a measurement tool or converted by a formula.
3More than 200 patients were enrolled.
4One study did not mention the randomization method, and one study did not mention how the blindness method was implemented.
5Several studies did not mention the randomization and blindness methods.
6One study did not mention the randomization and blindness methods.
7More than 500 patients were enrolled.
GRADE evidence profile for the time to the first rescue analgesic.
| Quality assessment | No. of patients | Effect | Quality | Importance | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| No. of studies | Design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | TAP | Wl | Absolute (95% CI) | ||
| Time to the first rescue analgesic (better indicated by lower values) | |||||||||||
| 2 | Randomized trials | Serious1 | No serious inconsistency | No serious indirectness | No serious imprecision | None | 56 | 56 | MD 2.15 higher (0.05 to 4.25 higher) | Moderate | Important |
1Some studies did not mention the randomization or blindness method.
GRADE evidence profile for postoperative nausea and vomiting (PONV) incidence and patient satisfaction.
| Quality assessment | No. of patients | Effect | Quality | Importance | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No. of studies | Design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | TAP | Wl | Absolute (95% CI) | |||
| Postoperative nausea and vomiting (PONV) incidence | ||||||||||||
| 4 | Randomized trials | No serious | No serious inconsistency | No serious indirectness | No serious imprecision | None | 36/141 (25.5%) | 36/139 (25.9%) | RR 0.97 (0.66 to 1.43) | 8 fewer per 1000 (from 88 fewer to 111 more) | High | Important |
| 27% | 8 fewer per 1000 (from 92 fewer to 116 more) | |||||||||||
| Patient satisfaction (better indicated by lower values) | ||||||||||||
| 3 | Randomized trials | No serious | No serious inconsistency | No serious indirectness | No serious imprecision | None | 107 | 105 | — | MD 1.27 higher (0.22 to 2.32 higher) | High | Critical |
Figure 4Postoperative pain scores at rest at 1 h.
Figure 5Postoperative pain scores at rest at 2 h.
Figure 6Postoperative pain scores at rest at 4 h.
Figure 7Postoperative pain scores at rest at 6 h.
Figure 8Postoperative pain scores at rest at 12 h.
Figure 9Postoperative pain scores at rest at 24 h.
Figure 10Postoperative pain scores during movement at 1 h.
Figure 11Postoperative pain scores during movement at 2 h.
Figure 12Postoperative pain scores during movement at 4 h.
Figure 13Postoperative pain scores during movement at 6 h.
Figure 14Postoperative pain scores during movement at 24 h.
Figure 15Time to the first rescue analgesic.
Figure 16Postoperative nausea and vomiting (PONV) incidence.
Figure 17Patient satisfaction.
Figure 18Funnel plot of pain scores at rest at 1 h.
Figure 19Funnel plot of pain scores at rest at 2 h.
Figure 20Funnel plot of pain scores at rest at 6 h.
Figure 21Funnel plot of pain scores at rest at 12 h.
Figure 22Funnel plot of pain scores at rest at 24 h.
Figure 23Funnel plot of pain scores during movement at 24 h.
Figure 24Funnel plot of PONV incidence.
Sensitivity analysis of the pain score.
| Pain score statistics with each study removed | |||||
|---|---|---|---|---|---|
| Study | MD | 95% CI lower limit | 95% CI upper limit |
|
|
| TAP VS WI at rest at 1 h | |||||
| Atim, A. [ | -0.20 | -0.74 | 0.35 | 0.71 | 0.48 |
| El sharkwy, I. A. [ | -0.36 | -1.31 | 0.58 | 0.75 | 0.45 |
| Ortiz, J. [ | -0.44 | -0.98 | 0.10 | 1.59 | 0.11 |
| Skjelsager, A. [ | -0.46 | -1.16 | 0.24 | 1.29 | 0.20 |
| Tolchard, S. [ | -0.20 | -0.76 | 0.37 | 0.67 | 0.50 |
| TAP VS WI at rest at 2 h | |||||
| Atim, A. [ | -0.70 | -1.18 | -0.21 | 2.8 | 0.005 |
| Li, Q. [ | -0.70 | -1.25 | -0.15 | 2.48 | 0.01 |
| Ortiz, J. [ | -0.81 | -1.29 | -0.32 | 3.28 | 0.001 |
| Skjelsager, A. [ | -0.97 | -1.50 | -0.44 | 3.56 | 0.0004 |
| Tolchard, S. [ | -0.65 | -1.15 | -0.15 | 2.56 | 0.01 |
| TAP VS WI at rest at 4 h | |||||
| Atim, A. [ | -0.50 | -1.11 | 0.11 | 1.60 | 0.11 |
| Ortiz, J. [ | -0.51 | -1.11 | 0.09 | 1.67 | 0.09 |
| Skjelsager, A. [ | -0.80 | -1.63 | 0.03 | 1.88 | 0.06 |
| TAP VS WI at rest at 6 h | |||||
| Atim, A. [ | -0.85 | -1.07 | -0.63 | 7.6 | <0.00001 |
| El sharkwy, I. A. [ | -0.79 | -1.17 | -0.41 | 4.1 | <0.0001 |
| Gorkem, U. [ | -0.87 | -1.09 | -0.65 | 7.82 | <0.00001 |
| Ibrahim, M. [ | -0.87 | -1.09 | -0.65 | 7.77 | <0.00001 |
| Skjelsager, A. [ | -0.90 | -1.13 | -0.68 | 7.85 | <0.00001 |
| TAP VS WI at rest at 12 h | |||||
| El sharkwy, I. A. [ | -0.56 | -1.03 | -0.09 | 2.33 | 0.02 |
| Gorkem, U. [ | -0.80 | -0.93 | -0.66 | 11.67 | <0.00001 |
| Ibrahim, M. [ | -0.79 | -0.93 | -0.65 | 11.42 | <0.00001 |
| Ortiz, J. [ | -0.78 | -0.91 | -0.64 | 11.41 | <0.00001 |
| TAP VS WI at rest at 24 h | |||||
| Atim, A. [ | -0.52 | -0.72 | -0.32 | 5.08 | <0.00001 |
| El sharkwy, I. A. [ | -0.64 | -0.85 | -0.44 | 6.13 | <0.00001 |
| Li, Q. [ | -0.53 | -0.71 | -0.35 | 5.63 | <0.00001 |
| Mughal, A. [ | -0.53 | -0.72 | -0.34 | 5.39 | <0.00001 |
| Ortiz, J. [ | -0.55 | -0.73 | -0.36 | 5.81 | <0.00001 |
| Rashid, A. [ | -0.55 | -0.73 | -0.37 | 5.92 | <0.00001 |
| Ruiz-Tovar [ | -0.47 | -0.69 | -0.25 | 4.19 | <0.0001 |
| Skjelsager, A. [ | -0.58 | -0.78 | -0.39 | 5.87 | <0.00001 |
| TAP VS WI during movement at 1 h | |||||
| Atim, A. [ | -0.60 | -1.93 | 0.73 | 0.88 | 0.38 |
| Skjelsager, A. [ | -1.70 | -3.34 | -0.06 | 2.03 | 0.04 |
| TAP VS WI during movement at 2 h | |||||
| Atim, A. [ | -1.23 | -2.29 | -0.16 | 2.25 | 0.02 |
| Li, Q. [ | -1.34 | -2.28 | -0.41 | 2.81 | 0.005 |
| Skjelsager, A. [ | -1.96 | -3.12 | -0.80 | 3.32 | 0.0009 |
| TAP VS WI during movement at 4 h | |||||
| Atim, A. [ | -0.79 | -1.53 | -0.05 | 2.10 | 0.04 |
| Ibrahim, M. [ | -0.44 | -1.19 | 0.30 | 1.17 | 0.24 |
| Skjelsager, A. [ | -0.70 | -1.39 | -0.02 | 2.00 | 0.05 |
| TAP VS WI during movement at 6 h | |||||
| Atim, A. [ | -0.67 | -1.37 | 0.02 | 1.89 | 0.06 |
| Ibrahim, M. [ | -0.65 | -1.26 | -0.04 | 2.07 | 0.04 |
| Skjelsager, A. [ | -0.84 | -1.38 | -0.30 | 3.03 | 0.002 |
| TAP VS WI during movement at 24 h | |||||
| Atim, A. [ | -0.79 | -1.25 | -0.33 | 3.39 | 0.0007 |
| Li, Q. [ | -0.81 | -1.14 | -0.48 | 4.84 | <0.00001 |
| Mughal, A. [ | -0.91 | -1.29 | -0.53 | 4.69 | <0.00001 |
| Rashid, A. [ | -0.87 | -1.19 | -0.55 | 5.30 | <0.00001 |
| Skjelsager, A. [ | -0.84 | -1.18 | -0.50 | 4.86 | <0.00001 |